[Early results of combined drug therapy of malignant lymphoma with chlormethin hydrochloride, vincristine, procarbazine and prednisone].
D000328:Adult; D000368:Aged; D004359:Drug Therapy, Combination; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage* / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage* / Q000627:therapeutic use; D011344:Procarbazine / Q000008:administration & dosage* / Q000627:therapeutic use; D014750:Vincristine / Q000008:administration & dosage* / Q000627:therapeutic use
D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone
Wczesne wyniki skojarzonego leczenia chłoniaków złośliwych nitrogranulogenem, winkrystyna, prokarbazyna i enkortonem (MOPP).